Skip to main content
OpenTrials
Completed

NCT Number: NCT05897931

Effects of Two Different Applications in Fibromyalgia

The study aims to determine the effect of connective tissue massage and taping applications on the pain and depression complaints of fibromyalgia patients and to compare their impact on quality of life.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Fibromyalgia Muscular Diseases Musculoskeletal Diseases Nervous System Diseases Neuromuscular Diseases Rheumatic Diseases

Age range

20 year–55 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Yeditepe University

Istanbul, Turkey (Türkiye)

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Being diagnosed with fibromyalgia.
  • Be in the age range of 20 - 55 years.
  • To be a volunteer participant in the research.
  • Being able to communicate comfortably.
  • To be able to act independently.

Exclusion criteria

  • Having had a surgical operation within the last year.
  • Presence of significant infection.
  • Being diagnosed with cancer.
  • Being pregnant or breastfeeding.
  • Being addicted to drugs or alcohol.
  • Having a cognitive problem.

Treatment and study plan

Connective Tissue Massage

Other

Connective Tissue Massage will be applied by starting from the lumbosacral region, continuing from the lower thoracic region, and finishing by applying it to the scapular region, interscapular region, and cervico-occipital region.

Kinesio Tape application

Other

Taping will be applied to the levator scapula and upper trapezius muscles in a "Y" shape, with 25% tension and while the participants were in an upright position. Again in the same position, this time the "C" shaped taping technique will be adhered with 50% tension from the middle fibers of the trapezium to the last rib.

Primary outcomes

  1. Visual Analogue Scale

    Time frame: 4 weeks

    Visual Analogue Scale (VAS) will be used to assess pain severity. In the assessment, the patient is asked to mark pain intensity on a 10-centimeter line that no pain is 0, and the most severe pain is 10.

Secondary outcomes

  1. Fibromyalgia Impact Questionnaire

    Time frame: 4 weeks

    The questionnaire assesses the functional status of patients with fibromyalgia. The scale consists of 20 questions that measure physical function, well-being, difficulty in doing work, not being able to go to work, fatigue, stiffness, morning fatigue, pain, anxiety, and depression separately. Low scores indicate improvement or less effect in patients.

  2. McGill Pain Questionnaire

    Time frame: 4 weeks

    The quality of the pain felt by the patients will be evaluated with the Short Form McGill Pain Questionnaire. The level of severity felt by the patient is evaluated with a number scale (0=no, 1=mild, 2=moderate, 3=severe), and higher scores show severe pain intensity.

  3. Beck's Depression Inventory

    Time frame: 4 weeks

    The Beck's Depression Inventory (BDI) is a 21-item self-assessment scale that evaluates the patients' perceived depressive symptoms quantitatively and measures the symptoms of depression. The higher scores indicate the severity of the patient's depression. It has been suggested that those who score 17 and above on the BDI may constitute an at-risk group.

  4. Short Form-36 Quality of Life Scale

    Time frame: 4 weeks

    The scale assesses the quality of life. The scale consists of 36 items evaluated in 8 separate subscales. The score from each subscale is between 0-100, and a higher score indicates better quality of life.

Sponsors and collaborators

Lead sponsor

Biruni University

Other

Registry information

Official study title

Effects of Connective Tissue Massage and Taping in Patients With Fibromyalgia

Important dates

Study start
2023
Primary completion
2023
Study completion
2023
First posted
Jun 9, 2023
Registry last updated
Jul 11, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.